quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:29:34·584d
SECFiling
Altamira Therapeutics Ltd. logo

Amendment: SEC Form F-1/A filed by Altamira Therapeutics Ltd.

CYTO· Altamira Therapeutics Ltd.
Health Care
Original source

Companies

  • CYTO
    Altamira Therapeutics Ltd.
    Health Care

Related

  • SEC489d
    SEC Form 6-K filed by Altamira Therapeutics Ltd.
  • PR489d
    Altamira Therapeutics Announces Transition from NASDAQ to OTC Markets
  • 13D/G525d
    SEC Form SC 13G filed by Altamira Therapeutics Ltd.
  • SEC566d
    SEC Form 6-K filed by Altamira Therapeutics Ltd.
  • PR566d
    Altamira Therapeutics Provides Update on Nasdaq Listing
  • PR573d
    Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray
  • SEC576d
    SEC Form 6-K filed by Altamira Therapeutics Ltd.
  • PR576d
    Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022